Stereotactic ablative radiotherapy (SABR) as primary, adjuvant, consolidation and re-treatment option in pancreatic cancer: scope for dose escalation and lessons for toxicity

Abstract Background Stereotactic ablative radiotherapy (SABR) offers an alternative treatment for pancreatic cancer, with the potential for improved tumour control and reduced toxicity compared with conventional therapies. However, optimal dose planning and delivery strategies are unelucidated and g...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:Radiation Oncology
المؤلفون الرئيسيون: Christy Goldsmith, P. Nicholas Plowman, Melanie M. Green, Roger G. Dale, Patricia M. Price
التنسيق: مقال
اللغة:الإنجليزية
منشور في: BMC 2018-10-01
الموضوعات:
Stereotactic ablative radiotherapy (SABR)
Cyberknife®
Pancreatic cancer
Radiobiology
Dose escalation
Local control
الوصول للمادة أونلاين:http://link.springer.com/article/10.1186/s13014-018-1138-3

الانترنت

http://link.springer.com/article/10.1186/s13014-018-1138-3

مواد مشابهة